Effects of antirheumatic drugs on human erythrocyte membranes.
D062365:Aminobenzoates / Q000494:pharmacology; D000700:Analgesics / Q000008:administration & dosage / Q000494:pharmacology*; D000983:Antipyrine / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects*; D004912:Erythrocytes / Q000187:drug effects*; D005439:Flufenamic Acid / Q000494:pharmacology; D006461:Hemolysis / Q000187:drug effects*; D006358:Hot Temperature; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008528:Mefenamic Acid / Q000494:pharmacology; D010113:Oxyphenbutazone / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D012980:Sodium Salicylate / Q000494:pharmacology; D013997:Time Factors
D062365:Aminobenzoates; D000700:Analgesics; D001463:Barbiturates; D001565:Benzoates; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D001241:Aspirin; D000983:Antipyrine; D012980:Sodium Salicylate; D007213:Indomethacin